Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydrocortison (ausschl Dafo TAB), ATC H02AB09 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerungsoption 1x12 Monate)
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- acis Arzneimittel GmbH, mibe GmbH Arzneimittel, Puren Pharma GmbH & Co. KG, Zentiva Pharma GmbH
- Contract value
- no value published
- Bids received
- 5
- Published
- 28 May 2026
- Awarded
- 1 Oct 2025
- Contract start
- 1 Oct 2025
- Contract end
- 14 Oct 2026estimated
- Region
- Hamburg